Tempus Wealth Planning, LLC Amgen Inc Transaction History

Tempus Wealth Planning, LLC

$255 Million
Q3 2024

A detailed history of Tempus Wealth Planning, LLC transactions in Amgen Inc stock. As of the latest transaction made, Tempus Wealth Planning, LLC holds 5,518 shares of AMGN stock, worth $1.55 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

5,518

Previous 5,290 4.31%

Holding current value

$1.55 Million

Previous $1.65 Million 7.57%

% of portfolio

0.7%

Previous 0.73%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$309.38 - $337.38 $70,538 - $76,922	228 Added 4.31%	5,518 $1.78 Million
Q2 2024 Jul 25, 2024	BUY	$262.75 - $319.31 $30,479 - $37,039	116 Added 2.24%	5,290 $1.65 Million
Q1 2024 Apr 19, 2024	BUY	$268.87 - $324.56 $9,410 - $11,359	35 Added 0.68%	5,174 $1.47 Million
Q4 2023 Jan 23, 2024	SELL	$255.7 - $288.46 $19,433 - $21,922	-76 Reduced 1.46%	5,139 $1.48 Million
Q3 2023 Oct 31, 2023	SELL	$218.65 - $271.46 $655 - $814	-3 Reduced 0.06%	5,215 $1.4 Million
Q2 2023 Jul 21, 2023	BUY	$214.27 - $253.37 $37,497 - $44,339	175 Added 3.47%	5,218 $1.16 Million
Q1 2023 May 08, 2023	BUY	$225.79 - $275.2 $10,837 - $13,209	48 Added 0.96%	5,043 $1.22 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $48,325 - $61,403	-211 Reduced 4.05%	4,995 $1.31 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $116,494 - $131,384	519 Added 11.07%	5,206 $1.17 Million
Q2 2022 Aug 05, 2022	SELL	$230.71 - $256.74 $44,527 - $49,550	-193 Reduced 3.95%	4,687 $1.14 Million
Q1 2022 May 06, 2022	SELL	$219.27 - $242.57 $264,220 - $292,296	-1,205 Reduced 19.8%	4,880 $1.18 Million
Q4 2021 Feb 02, 2022	BUY	$198.88 - $227.6 $69,608 - $79,660	350 Added 6.1%	6,085 $1.37 Million
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $124,177 - $145,489	585 Added 11.36%	5,735 $1.22 Million
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $719,893 - $798,669	3,082 Added 149.03%	5,150 $1.26 Million
Q1 2021 Apr 29, 2021	BUY	$221.91 - $258.6 $83,660 - $97,492	377 Added 22.29%	2,068 $515,000
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $45,872 - $54,626	212 Added 14.33%	1,691 $389,000
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $31,208 - $34,706	-133 Reduced 8.25%	1,479 $376,000
Q2 2020 Aug 07, 2020	SELL	$197.81 - $242.74 $10,681 - $13,107	-54 Reduced 3.24%	1,612 $380,000
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $10,023 - $13,293	55 Added 3.41%	1,666 $338,000
Q4 2019 Mar 16, 2020	BUY	$189.21 - $243.2 $304,817 - $391,795	1,611 New	1,611 $388,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tempus Wealth Planning, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tempus Wealth Planning, LLC with notifications on news.

Account

Tempus Wealth Planning, LLC Amgen Inc Transaction History